Literature DB >> 8507558

P19 embryonal carcinoma cells.

M W McBurney1.   

Abstract

P19 cells are a line of pluripotent embryonal carcinoma able to grow continuously in serum-supplemented media. The differentiation of these cells can be controlled by nontoxic drugs. Retinoic acid effectively induces the development of neurons, astroglia and microglia--cell types normally derived from the neuroectoderm. Aggregates of P19 cells exposed to dimethyl sulfoxide differentiate into endodermal and mesodermal derivatives including cardiac and skeletal muscle. P19 cells can be effectively transfected with DNA encoding recombinant genes and stable lines expressing these genes can be readily isolated. These manipulations make P19 cells suitable material for investigating the molecular mechanisms governing developmental decision made by differentiating pluripotent cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8507558

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  117 in total

1.  Reconstitution of cyclin D1-associated kinase activity drives terminally differentiated cells into the cell cycle.

Authors:  L Latella; A Sacco; D Pajalunga; M Tiainen; D Macera; M D'Angelo; A Felici; A Sacchi; M Crescenzi
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  Tbx6 is a determinant of cardiac and neural cell fate decisions in multipotent P19CL6 cells.

Authors:  Svetlana Gavrilov; Thomas G Nührenberg; Anthony W Ashton; Chang-Fu Peng; Jennifer C Moore; Klitos Konstantinidis; Christine L Mummery; Richard N Kitsis
Journal:  Differentiation       Date:  2012-06-19       Impact factor: 3.880

3.  Menin induces endodermal differentiation in aggregated P19 stem cells by modulating the retinoic acid receptors.

Authors:  Jyotshnabala Kanungo; Settara C Chandrasekharappa
Journal:  Mol Cell Biochem       Date:  2011-08-11       Impact factor: 3.396

4.  Arsenic exposure inhibits myogenesis and neurogenesis in P19 stem cells through repression of the β-catenin signaling pathway.

Authors:  Gia-Ming Hong; Lisa J Bain
Journal:  Toxicol Sci       Date:  2012-05-28       Impact factor: 4.849

5.  Dynamic DNA methylation and histone modifications contribute to lentiviral transgene silencing in murine embryonic carcinoma cells.

Authors:  Jin He; Qing Yang; Lung-Ji Chang
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

6.  HoxB domain induction silences DNA replication origins in the locus and specifies a single origin at its boundary.

Authors:  Damien Grégoire; Konstantin Brodolin; Marcel Méchali
Journal:  EMBO Rep       Date:  2006-07-14       Impact factor: 8.807

7.  Directed differentiation of mouse P19 embryonal carcinoma cells to neural cells in a serum- and retinoic acid-free culture medium.

Authors:  Isha Verma; Polani B Seshagiri
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-07-20       Impact factor: 2.416

Review 8.  Headway and hurdles in the clinical development of dietary phytochemicals for cancer therapy and prevention: lessons learned from vitamin A derivatives.

Authors:  Christina Y Yim; Pingping Mao; Michael J Spinella
Journal:  AAPS J       Date:  2014-01-16       Impact factor: 4.009

9.  Induction of CYP26A1 by metabolites of retinoic acid: evidence that CYP26A1 is an important enzyme in the elimination of active retinoids.

Authors:  Ariel R Topletz; Sasmita Tripathy; Robert S Foti; Jakob A Shimshoni; Wendel L Nelson; Nina Isoherranen
Journal:  Mol Pharmacol       Date:  2014-12-09       Impact factor: 4.436

10.  Formation of embryoid bodies from mouse embryonic stem cells cultured on silicon-coated surfaces.

Authors:  Fardin Fathi; Taki Altiraihi; Seyed Javad Mowla; Mansoreh Movahedin
Journal:  Cytotechnology       Date:  2009-03-18       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.